The role of tetramerization in p53 function

作者: Patrick Chène

DOI: 10.1038/SJ.ONC.1204373

关键词:

摘要: The tumour suppressor gene p53 is extensively studied for its importance in cancer. In active conformation, tetrameric and one domain - the tetramerization permits oligomerization of this protein. Until recently, little attention was given to because, contrast DNA-binding domain, it not often mutated However, various experimental studies have shown evidence that essential DNA binding, protein-protein interactions, post-translational modifications, degradation. Moreover, single mutations can inactivate wild-type protein a manner similar seen with domain. Interestingly, phenotype several mutants differs from observed mutants. review, current knowledge about function will be summarized.

参考文章(89)
Frank McCormick, Robin Clark, Ed Harlow, Robert Tjian, SV40 T antigen binds specifically to a cellular 53 K protein in vitro Nature. ,vol. 292, pp. 63- 65 ,(1981) , 10.1038/292063A0
Patrick Chène, Influence of the N-terminal region on the oligomerisation between human and Xenopus laevis p53 Journal of Molecular Biology. ,vol. 288, pp. 883- 890 ,(1999) , 10.1006/JMBI.1999.2734
Maria Malanga, Jutta M. Pleschke, Hanna E. Kleczkowska, Felix R. Althaus, Poly(ADP-ribose) Binds to Specific Domains of p53 and Alters Its DNA Binding Functions Journal of Biological Chemistry. ,vol. 273, pp. 11839- 11843 ,(1998) , 10.1074/JBC.273.19.11839
P. N. Friedman, X. Chen, J. Bargonetti, C. Prives, The p53 protein is an unusually shaped tetramer that binds directly to DNA. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 90, pp. 3319- 3323 ,(1993) , 10.1073/PNAS.90.8.3319
Timothy S. Davison, Christine Vagner, Mourad Kaghad, Ayeda Ayed, Daniel Caput, Cheryl H. Arrowsmith, p73 and p63 Are Homotetramers Capable of Weak Heterotypic Interactions with Each Other but Not with p53 Journal of Biological Chemistry. ,vol. 274, pp. 18709- 18714 ,(1999) , 10.1074/JBC.274.26.18709
K. Roemer, Mutant p53: gain-of-function oncoproteins and wild-type p53 inactivators. Biological Chemistry. ,vol. 380, pp. 879- 887 ,(1999) , 10.1515/BC.1999.108
M Hollstein, D Sidransky, B Vogelstein, C. Harris, p53 mutations in human cancers Science. ,vol. 253, pp. 49- 53 ,(1991) , 10.1126/SCIENCE.1905840
G. Clore, J. Omichinski, K. Sakaguchi, N. Zambrano, H. Sakamoto, E. Appella, A. Gronenborn, Interhelical Angles in the Solution Structure of the Oligomerization Domain of p53: Correction Science. ,vol. 267, pp. 1515- 1516 ,(1995) , 10.1126/SCIENCE.7878474